12:00 AM
Dec 14, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BG-12: Completed Phase II enrollment

Biogen Idec completed enrollment of 150 patients in a double-blind, placebo-controlled, international Phase II study evaluating oral BG-12 for...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >